Soru

Passage:
For over a century, the central dogma of structural biology has been predicated on the "lock-and-key" model first proposed by Emil Fischer in 1894. This paradigm asserts that a protein's biological function is strictly dictated by its stable, three-dimensional geometric structure. According to this traditional view, the precise folding of amino acid chains creates specific, rigid active sites—the "locks"—into which only specific molecular substrates—the "keys"—can fit. This structure-function paradigm has been so dominant that proteins lacking a defined three-dimensional conformation were historically dismissed as nonfunctional anomalies or experimental artifacts resulting from in vitro degradation.

However, the advent of advanced nuclear magnetic resonance (NMR) spectroscopy in the late twentieth century catalyzed a paradigm shift, revealing the widespread existence of intrinsically disordered proteins (IDPs). Unlike their well-structured counterparts, IDPs exist as highly dynamic structural ensembles, interconverting rapidly among numerous conformational states. Remarkably, this lack of stable structure does not preclude functionality; rather, it is the very basis of their biological roles. Many IDPs function via a mechanism known as "coupled folding and binding," wherein the disordered protein undergoes a structural transition to a folded state only upon interaction with a specific physiological partner. Others form "fuzzy complexes," retaining a significant degree of structural disorder even when bound to a target, which allows for highly flexible and reversible interactions.

The evolutionary proliferation of IDPs, particularly in complex eukaryotes, appears inextricably linked to their crucial roles in cellular signaling and regulatory networks. A rigid protein is typically constrained to interacting with a single, highly complementary binding partner. In contrast, the conformational plasticity of an IDP allows a single protein to act as a central hub, capable of interacting promiscuously yet specifically with multiple structurally distinct downstream targets. This "one-to-many" binding capability facilitates intricate regulatory cross-talk and rapid integration of diverse cellular signals without necessitating a correspondingly massive increase in genome size.

Despite their biological importance, IDPs present formidable challenges to contemporary pharmacology. Traditional rational drug design overwhelmingly relies on identifying and targeting stable binding pockets on the surface of rigid proteins. Because IDPs lack these permanent topological features, they are generally considered "undruggable" by conventional small-molecule therapeutics. Consequently, pharmaceutical research is increasingly pivoting toward alternative strategies, such as developing compounds that stabilize an IDP in an inactive conformation prior to target binding.

Based on the passage, the author states that the lack of a stable structure in intrinsically disordered proteins allows them to do which one of the following?